報價延遲最少15分鐘:2025/01/21 08:49 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.46/2.15
|
|
企業價值
751.50M
|
| 資產負債 |
|
每股賬面淨值
6.58
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
65.56M
|
|
每股收益
4.97
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:49 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States. |